Basal ganglia: new therapeutic approaches to Parkinson's disease.
Graybiel
A M
AM
Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge 02139, USA.
D000818:Animals; D001479:Basal Ganglia / Q000378:metabolism*; D001480:Basal Ganglia Diseases / Q000628:therapy; D006801:Humans; D007980:Levodopa / Q000494:pharmacology; D009414:Nerve Growth Factors / Q000235:genetics / Q000627:therapeutic use; D009493:Neurosurgery; D010300:Parkinson Disease / Q000628:therapy*; D014446:Tyrosine 3-Monooxygenase / Q000235:genetics / Q000378:metabolism
D009414:Nerve Growth Factors; D007980:Levodopa; D014446:Tyrosine 3-Monooxygenase